期刊文献+

F/T-PSA比值联合前列腺穿刺在诊断灰区前列腺癌中临床研究 被引量:3

原文传递
导出
摘要 总前列腺特异性抗原(T-PSA)处于4~10 ng/ml被称为前列腺癌诊断灰区,前列腺增生(BPH)与前列腺癌(PCa)难以鉴别,F-PSA为游离前列腺特异性抗原(F-PSA)与T-PSA的比值(F/T-PSA)能提高前列腺癌穿刺的阳性率。我院于2009年1月至2012年12月结合F/T-PSA比值,应用超声引导下经直肠前列腺穿刺诊断PCa,效果满意,现报告如下。
出处 《中国男科学杂志》 CAS CSCD 北大核心 2013年第12期54-55,共2页 Chinese Journal of Andrology
基金 广西贵港市科学技术技项目
  • 相关文献

参考文献5

二级参考文献29

  • 1王洪亮,张灵,张海峰,许宁,计国义,潘玉琢,高洪文,赵雪俭.经直肠超声前列腺癌声像特征及前列腺内腺PSA密度在前列腺癌诊断中的作用[J].中国老年学杂志,2005,25(7):786-788. 被引量:7
  • 2李贵忠,刘流,黄广林,王建伟,刘宁,曾荔,张军,袁亦铭,杨新宇,冯陶,那彦群.f/tPSA比值对tPSA值为2.6~4.0ng/ml前列腺癌的诊断意义[J].中国男科学杂志,2006,20(3):43-46. 被引量:4
  • 3Brawer MK. Prostate specific antigen: current status. CA Cancer J Clin, 1999, 49:264-268.
  • 4Hodge KK, Mcneal JE, Ten'is MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol, 1989, 142:71-75.
  • 5Elabbady AA, Khedr MM. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score. Eur Urol, 2006, 49: 49-53.
  • 6Rajbabu K, Chandrasekera S, Zhu G, et al. Racial origin is associated with poor awareness of prostate cancer in UK men, but can be increased by simple information. Prostate Cancer Prostatic Dis, 2007, 10:256-260.
  • 7Eskicorapci SY, Baydar DE, Akbal C, et al . An extended 10- core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer. Eur Urol, 2004, 45 : 444-448.
  • 8Philip J, Ragavan N, Desouza J, et al. Effect of peripheral biopsies in maximising early prostate cancer detection in 8-, 10- or 12-core biopsy regimens. BJU Int, 2004, 93..1218-1220.
  • 9Hara R, Jo Y, Fujii T, et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology, 2008, 71:191-195.
  • 10王寅 黄长海 等.前列腺特异抗原不同评价结果与前列腺癌的关系分析[J].中华医学杂志,2000,80(9):678-680.

共引文献75

同被引文献42

  • 1周永昌,郭万学.超声医学.4版.北京:科技技术文献出版社,2002:235-236.
  • 2Hodge KK,Mc Neal JE,Terris MK,et al.Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.J Urol,1989,142(1):7l-74.
  • 3Hossack T,Patel MI,Huo A,et al.Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy.J Urol,2012,188(3):781-785.
  • 4Sartor AO,Hricak H,Wheeler TM,et al.Evaluating localized prostate cancer and identifying candidates for focal therapy.Urology,2008,72(6 Suppl):S12-S24.
  • 5Pinto F, Totaro A, Palermo G, et al. Imaging in prostate cancer diagnsis; present role and fu- ture perspectives. UrolInt 2011; 86(4): 373-382.
  • 6Pienta ICI. Critical appraisal of prostate-specific antigen in prostate screening:20 years laster. Urology 2009; 73(5 Suppl): S11-S20.
  • 7Schrder FH, Hugosson J, Roobol M J, et al. Screening and prostatecancer in a randomized European study. NEngl J Meal2009; 360(13): 1320-1328.
  • 8Veltri RW, Miller MC, Oflowd GJ, eta1. Impact of age on total and complexed prostate- specific antigen cutoffs in acontemperary referral series of men with prostate cancer. Urology 2002; 60(4Suppl 1): 47-52.
  • 9Nadler RB, Humphrey PA, Smith DS, et al. Effect ofintlammation and benign pro- static hyperplasia on elevated serum prostate-specific antigen levels. J Urol 1995; 154(2 Pt 1): 407-413.
  • 10Hodge KK, Mcneal J E, Stamey TA. U Ltrasoundguided transrectal core biopsies of the pa-lpably abnormal prostate. J Urol 1989; 142(1): 66-70.

引证文献3

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部